Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MedPal AILSE:MPAL -4.76% Equity-to-Asset is 0.22 as of Feb. 2026, which is at its 10-year median of 0.22. The stock has 1 warning sign investors should review. Among 687 Healthcare Providers & Services companies, MedPal AI ranks worse than 80.49% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. MedPal AI's Total Stockholders Equity for the quarter that ended in Feb. 2026 was £0.51 Mil. MedPal AI's Total Assets for the quarter that ended in Feb. 2026 was £2.32 Mil.
Therefore, MedPal AI's Equity to Asset Ratio for the quarter that ended in Feb. 2026 was 0.22.
The historical rank and industry rank for MedPal AI's Equity-to-Asset or its related term are showing as below:
LSE:MPAL'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.36 Med: 0.22 Max: 0.68
Current: 0.22
During the past 4 years, the highest Equity to Asset Ratio of MedPal AI was 0.68. The lowest was -0.36. And the median was 0.22.
LSE:MPAL's Equity-to-Asset is ranked worse than 80.49% of 687
companies
in the Healthcare Providers & Services industry
Industry Median: 0.49
vs LSE:MPAL: 0.22
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
MedPal AI Equity-to-Asset Related Terms
MedPal AI Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for MedPal AI's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI Equity-to-Asset Chart
MedPal AI Annual Data
Trend
Aug22
Aug23
Aug24
Aug25
Equity-to-Asset
0.27
-0.18
-0.37
0.68
MedPal AI Semi-Annual Data
Feb24
Aug24
Feb25
Aug25
Feb26
Equity-to-Asset
-0.02
-0.37
-1.15
0.68
0.22
LSE:MPAL vs VEEV, BTSG, TEM: Equity-to-Asset Comparison
For the Health Information Services subindustry, MedPal AI's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MedPal AI Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MedPal AI's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where MedPal AI's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
MedPal AI's Equity to Asset Ratio for the fiscal year that ended in Aug. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MedPal AI (LSE:MPAL) has a Equity-to-Asset of 0.22 as of Feb. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on MedPal AI and its competitors. This is near median its historical median of 0.22. According to the industry distribution chart, MedPal AI ranks #553 out of 687 companies in the Healthcare Providers & Services industry, placing it in the top 80.5%.
Is MedPal AI's Equity-to-Asset too high?
MedPal AI's current Equity-to-Asset of 0.22 is near median its 10-year median of 0.22. The Healthcare Providers & Services industry median Equity-to-Asset is 0.49. MedPal AI's value of 0.22 is 55.1% below this industry median. Based on the distribution chart, MedPal AI ranks #553 out of 687 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does MedPal AI's Equity-to-Asset compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MedPal AI ranks #553 out of 687 companies for Equity-to-Asset. This places MedPal AI in the lower half of its industry. The industry median Equity-to-Asset is 0.49. MedPal AI's value of 0.22 is 55.1% below this benchmark. While the company's 10-year median is 0.22 vs. the industry median of 0.49, MedPal AI has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.49, based on 687 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MedPal AI's current Equity-to-Asset of 0.22 is 55.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on MedPal AI and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MedPal AI's current Equity-to-Asset is 0.22, which is near median its own 10-year median of 0.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MedPal AI stock overvalued right now?
MedPal AI (LSE:MPAL) has a current Equity-to-Asset of 0.22. The current Equity-to-Asset is 0.22, which is near median its 10-year median of 0.22 and 55.1% below the Healthcare Providers & Services industry median of 0.49. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For MedPal AI (LSE:MPAL), the current Equity-to-Asset is 0.22 as of Feb. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
MedPal AI PLC is a UK-based digital health and artificial intelligence company focused on the development and commercialisation of AI-enabled healthcare platforms.. Its platform aggregates data across devices and apps (including Apple Health, Fitbit, Garmin, and Google Fit) to deliver real-time, personalized health insights. The Company has two reportable segments, Software and Corporate.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LSE:MPAL has been successfully added to your 
